Pyfer Bryan, Chatterjee Abhishek, Chen Lilian, Nigriny John, Czerniecki Brian, Tchou Julia, Fisher Carla
Department of Surgery, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA.
Department of Surgery, University of Pennsylvania Health System, Philadelphia, PA, USA.
Ann Surg Oncol. 2016 Jan;23(1):92-8. doi: 10.1245/s10434-015-4770-2. Epub 2015 Jul 29.
Little has been studied that compares early postoperative outcomes between breast conservation surgery (BCS) and simple mastectomy with implant reconstruction (SM). Our goal was to utilize a large-volume database to compare such outcomes in women with early stage breast cancer.
The National Surgery Quality Improvement Program (NSQIP) database was searched for patients who underwent partial or complete mastectomy between 2009 and 2012. Exclusion criteria eliminated potential confounding factors. We compared preoperative comorbidities and postoperative complication rates between each treatment group by Chi square and two-sample t tests; we also determined the odds ratios for the likelihood of adverse events in a number of categories.
A total of 11,645 patients met the study criteria: 9571 underwent BCS and 2074 underwent SM with implant reconstruction. The baseline characteristics of the two groups showed significant differences for age (61.7 years in BCS, 53.5 years in SM), body mass index (29.6 kg/m(2) in BCS, 27.0 kg/m(2) in SM), and rates of hypertension (47.0 % in BCS, 25.6 % in SM), coronary artery disease (1.3 % in BCS, 0.6 % in SM), chronic obstructive pulmonary disease (2.4 % in BCS, 1.0 % in SM), and diabetes (11.7 % in BCS, 5.9 % in SM). Statistical analysis between each treatment modality revealed that the SM with implant group had significantly higher total complication (5.5 vs. 2.1 % in BCS), wound (2.8 vs. 1.4 % in BCS), infection (1.9 vs. 0.4 % in BCS), and bleeding (0.2 vs. 0.05 % in BCS) rates than the BCS group.
BCS has fewer overall early postoperative wound, infectious, and bleeding complications despite a significantly higher rate of preexisting risk factors.
关于保乳手术(BCS)和单纯乳房切除术加植入物重建术(SM)术后早期结果的比较研究较少。我们的目标是利用一个大容量数据库来比较早期乳腺癌女性的此类结果。
在国家外科质量改进计划(NSQIP)数据库中搜索2009年至2012年间接受部分或全乳切除术的患者。排除标准消除了潜在的混杂因素。我们通过卡方检验和双样本t检验比较了各治疗组术前合并症和术后并发症发生率;我们还确定了多个类别中不良事件发生可能性的比值比。
共有11645例患者符合研究标准:9571例行保乳手术,2074例行单纯乳房切除术加植入物重建术。两组的基线特征在年龄(保乳手术组为61.7岁,单纯乳房切除术组为53.5岁)、体重指数(保乳手术组为29.6kg/m²,单纯乳房切除术组为27.0kg/m²)以及高血压发生率(保乳手术组为47.0%,单纯乳房切除术组为25.6%)、冠状动脉疾病(保乳手术组为1.3%,单纯乳房切除术组为0.6%)、慢性阻塞性肺疾病(保乳手术组为2.4%,单纯乳房切除术组为1.0%)和糖尿病(保乳手术组为11.7%,单纯乳房切除术组为5.9%)方面存在显著差异。各治疗方式之间的统计分析显示,植入物重建的单纯乳房切除术组的总并发症发生率(5.5%对保乳手术组的2.1%)、伤口并发症发生率(2.8%对保乳手术组的1.4%)、感染发生率(1.9%对保乳手术组的0.4%)和出血发生率(0.2%对保乳手术组的0.05%)均显著高于保乳手术组。
尽管保乳手术组既往危险因素发生率显著较高,但其术后早期总体伤口、感染和出血并发症较少。